House Bill No. by Representative Edmonston aims to regulate the prescribing, administering, and dispensing of prescription drugs for off-label use by healthcare professionals with prescriptive authority. The bill enacts R.S. 37:1704, which defines "off-label use" as the use of a prescription drug for an indication not approved by the FDA, or in an age group, dosage, or route of administration that has not been sanctioned by the FDA.

The proposed law explicitly prohibits any healthcare professional licensing board or commission from restricting or prohibiting the off-label use of FDA-approved drugs. This change is intended to ensure that healthcare professionals can utilize their discretion in prescribing medications based on their clinical judgment without interference from licensing bodies.